Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$63.1B
sum of reported positions
Reported positions
341
Changes vs prior quarter
375
57 new · 49 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 304 measured positions in 8 quarters, the typical new or larger position finished −2.6 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 21.6M | $2.1B | 3.3% | |
| 13.7M | $1.98B | 3.1% | |
| 5.53M | $1.98B | 3.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $62.3B | $63.1B |
| Positions | 333 | 341 |
| Biggest line | — | Arch Capital Group 3% |
| 4.58M |
| $1.77B |
| 2.8% |
| 18.9M | $1.75B | 2.8% |
| 11.4M | $1.59B | 2.5% |
| 4.52M | $1.53B | 2.4% |
| 8.64M | $1.5B | 2.4% |
| 5.54M | $1.45B | 2.3% |
| 2.89M | $1.45B | 2.3% |
| 1.51M | $1.4B | 2.2% |
| 2.37M | $1.33B | 2.1% |
| 5.29M | $1.26B | 2.0% |
| 7.27M | $1.21B | 1.9% |
| 5.13M | $1.12B | 1.8% |
| 31.7M | $1.09B | 1.7% |
| 4.42M | $1.05B | 1.7% |
| 4.74M | $917M | 1.5% |
| 50.4M | $876M | 1.4% |
| 2.41M | $866M | 1.4% |
| 2.63M | $703M | 1.1% |
| 1.36M | $623M | 1.0% |
| 1.85M | $614M | 1.0% |
| 1.61M | $609M | 1.0% |
| 10.8M | $601M | 1.0% |
Citigroup (C) · PUT
560K shares
Astrazeneca (AZN)
368K shares
Caterpillar (CAT) · PUT
57K shares
Murphy USA (MUSA)
109K shares
Virtu Financial, Inc. (VIRT)
877K shares
Chefs' Warehouse, Inc. (CHEF)
335K shares
Weatherford International (WFRD)
379K shares
Illumina, Inc. (ILMN)
168K shares
Taiwan Semiconductor Manufacturing (TSM) · PUT
57K shares
Arrowhead Pharmaceuticals (ARWR)
311K shares
ISHARES TR
249K shares
Cerebras Systems (CBRS)
108K shares
American Homes 4 Rent (AMH)
620K shares
Neptune Insurance (NP)
655K shares
USA Rare Earth (USAR)
954K shares
MaxLinear, Inc. (MXL)
143K shares
Alamar Biosciences (ALMR)
614K shares
Jfrog (FROG)
155K shares
Arxis (ARXS)
274K shares
CANTOR EQUITY PARTNERS II IN
938K shares
Replimune Group (REPL)
973K shares
Waterbridge Infrastructure LLC (WBI)
314K shares
Danaher Corporation (DHR)
49K shares
Martin Marietta Materials (MLM)
16K shares
Antero Midstream (AM)
395K shares